-14.7billion yen-2.5billion yen(billion)(billion)201720182017201820172018Note1 : In December 2020, the Healthcare and Skincare business has been classified as a discontinued operation as a result of the decision to sell all shares in Qʼsai held by the Company. As a result, revenue, Business Income and EBITDA for 2020 and 2021 are the amounts for continuing operations excluding discontinued operations. This sale of shares was completed on February 1, 2021.Note2 : We introduce Business Income as a measure of our underlying or recurring business performance after the adoption of IFRS. Business Income deducts cost of goods and SG&A from revenue and includes other income and expenses which we believe are recurring in nature.Note3 : EBITDA = Business Income + depreciation and amortization expenses927.3837.122.0 10.153.142.5914.8792.0 785.8 -58.0-4.7-2.52021103.965.540.220192020202120202019201920202021(billion)(billion)(billion)20172018201920172018201920172018201940.223.315.0118.7113.865.581.672.070.80.22020-14.7126.4110.559.142.5202120202021(billion)2020202111Net Income Attributable to Owners of the ParentCapital ExpenditureRevenueCash and Cash Equivalents at End of Fiscal YearBusiness IncomeEBITDAFinancial Highlights (IFRS)Financial and Sustainability Highlights785.8billion yen40.2billion yen110.5billion yen42.5billion yen
元のページ ../index.html#12